feed,title,long_url,short_url
Benzinga,Diffusion Pharmaceuticals Names Director Dr. Robert Cobuzzi as President and Chief Executive Officer,https://www.benzinga.com/pressreleases/20/09/g17418801/diffusion-pharmaceuticals-names-director-dr-robert-cobuzzi-as-president-and-chief-executive-office,https://j.mp/32aNi99
Benzinga,Nkarta Announces September 2020 Virtual Investor Conference Schedule,https://www.benzinga.com/pressreleases/20/09/g17418800/nkarta-announces-september-2020-virtual-investor-conference-schedule,https://j.mp/3m5R5w2
Benzinga,Vir Biotechnology to Present at H.C. Wainwright 22nd Annual Global Investment Conference,https://www.benzinga.com/pressreleases/20/09/g17418777/vir-biotechnology-to-present-at-h-c-wainwright-22nd-annual-global-investment-conference,https://j.mp/3bBbZP2
Benzinga,"Agios Appoints Jonathan Biller as Chief Financial Officer, Head of Legal and Corporate Affairs",https://www.benzinga.com/pressreleases/20/09/g17418776/agios-appoints-jonathan-biller-as-chief-financial-officer-head-of-legal-and-corporate-affairs,https://j.mp/32cIBvw
Benzinga,Rubius Therapeutics to Participate at Upcoming Investor Conferences,https://www.benzinga.com/pressreleases/20/09/g17418775/rubius-therapeutics-to-participate-at-upcoming-investor-conferences,https://j.mp/33cBfaj
Benzinga,HTG Molecular Diagnostics to Present Corporate Overview at Fall Investor Conferences,https://www.benzinga.com/pressreleases/20/09/g17418773/htg-molecular-diagnostics-to-present-corporate-overview-at-fall-investor-conferences,https://j.mp/3bIlE6j
